The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 23.70
+0.30 (1.28%)
At close: Feb 10, 2026
BKK:KLINIQ Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 351.56 | 322.19 | 288.62 | 205.49 | 129.26 | 144.69 |
Depreciation & Amortization | 323.04 | 282.3 | 194.61 | 142 | 81.19 | 77.32 |
Loss (Gain) From Sale of Assets | 14.6 | 5.17 | -0.03 | 0.44 | 2.29 | 0.4 |
Asset Writedown & Restructuring Costs | - | - | -0 | -0.03 | - | 4.13 |
Other Operating Activities | -473.09 | -463.93 | -342.62 | -216.48 | -194.24 | -177.49 |
Change in Accounts Receivable | -13.28 | 5.08 | -9.56 | -1.41 | -0.59 | -9.08 |
Change in Inventory | -39.25 | -82.63 | -70.99 | -35.51 | 18.53 | -36.47 |
Change in Accounts Payable | 46.87 | 34.53 | 52.64 | 37.18 | 26.35 | -5.51 |
Change in Unearned Revenue | 467.93 | 451.73 | 326.59 | 334.25 | 183.82 | 237.55 |
Change in Other Net Operating Assets | -122.24 | -2.46 | -53.33 | -57.98 | -8.03 | 12.72 |
Operating Cash Flow | 556.15 | 551.98 | 385.92 | 407.96 | 238.56 | 248.26 |
Operating Cash Flow Growth | 13.54% | 43.03% | -5.40% | 71.01% | -3.91% | 274.71% |
Capital Expenditures | -289.15 | -571.67 | -366.52 | -225.79 | -72.92 | -148.33 |
Sale of Property, Plant & Equipment | 13.6 | 39.34 | 0.58 | - | 2.6 | 3.76 |
Sale (Purchase) of Intangibles | -0.65 | -1.13 | -0.59 | -1.16 | -1.12 | -0.22 |
Investment in Securities | 278.1 | 529.37 | -60.1 | -1,000 | - | - |
Other Investing Activities | 5.5 | 19.89 | 5.26 | 0.52 | 20.06 | 120.04 |
Investing Cash Flow | 7.4 | 15.79 | -421.37 | -1,226 | -51.37 | -24.76 |
Short-Term Debt Issued | - | - | - | - | - | 12.94 |
Total Debt Issued | - | - | - | - | - | 12.94 |
Short-Term Debt Repaid | - | - | - | - | -12.94 | - |
Long-Term Debt Repaid | - | -120.39 | -89.51 | -63.39 | -27.63 | -29.79 |
Total Debt Repaid | -131.84 | -120.39 | -89.51 | -63.39 | -40.57 | -29.79 |
Net Debt Issued (Repaid) | -131.84 | -120.39 | -89.51 | -63.39 | -40.57 | -16.85 |
Issuance of Common Stock | 20 | - | - | 1,470 | - | - |
Common Dividends Paid | -319 | -308 | -231 | -153.2 | -80 | -299.2 |
Other Financing Activities | - | - | - | -46.4 | - | - |
Financing Cash Flow | -430.84 | -428.39 | -320.51 | 1,207 | -120.57 | -316.05 |
Net Cash Flow | 132.7 | 139.38 | -355.96 | 388.54 | 66.62 | -92.55 |
Free Cash Flow | 266.99 | -19.7 | 19.39 | 182.17 | 165.64 | 99.93 |
Free Cash Flow Growth | - | - | -89.35% | 9.97% | 65.76% | - |
Free Cash Flow Margin | 7.89% | -0.66% | 0.85% | 11.11% | 17.44% | 9.99% |
Free Cash Flow Per Share | 1.21 | -0.09 | 0.09 | 1.07 | 1.03 | 0.63 |
Cash Interest Paid | 25.72 | 23.9 | 15.1 | 10.66 | 4.32 | 5.93 |
Cash Income Tax Paid | 85.44 | 64.42 | 55.28 | 35.39 | 22.17 | 21.04 |
Levered Free Cash Flow | 175.54 | -51.44 | -20.98 | 175.4 | 167.45 | - |
Unlevered Free Cash Flow | 191.62 | -36.5 | -11.54 | 182.06 | 170.15 | - |
Change in Working Capital | 340.04 | 406.25 | 245.35 | 276.53 | 220.06 | 199.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.